Publications by authors named "Yawana Tanapat"
Objective: To determine the prevalence of Human Papillomavirus (HPV) infection in patients with invasive cervical cancer after treatment by concurrent chemoradiation therapy.
Material And Method: Cervicovaginal mucous samples were collected from fifty-five patients with invasive cervical cancer two months after treatment completion and tested for HPV genotypes.
Results: Of the 55 patients, 31 (56.
Objective: To determine the survival rate of patients with adenocarcinoma of the cervix after completing treatment at Phramongkutklao Hospital.
Material And Method: Retrospective review of medical records of 229 patients with adenocarcinoma of the cervix who had completed treatment at Phramongkutklao Hospital between October 1991 to September 2006.
Results: Overall 2, 5 and 10-year survival for patients with adenocarcinoma of the cervix was 78.
Objective: To evaluate the efficiency of quality control performance for a general x-ray machine between computed radiography (CR) and film method.
Material And Method: CR performance as a quality control method for a general x-ray machine was compared to the film method. Two raters independently analyzed the result of quality control from both methods.
Objective: To evaluate agreement in pathologic diagnosis of tissue obtained by colposcopic directed biopsy (CDB) and conization or total abdominal hysterectomy (TAH) in the diagnosis of cervical intraepithelial neoplasia (CIN).
Material And Method: Medical records of women with abnormal cervical cytology referred for colposcopic examination from January 1, 1999 to December 31, 2003 were reviewed. Agreement in diagnosis of CIN in tissue obtained by CDB and tissue obtained by conization or TAH is defined as not more than one level of CIN disparity.
Objective: To determine the prevalence and risk factors of urinary incontinence in menopausal women at Phramongkutklao Hospital.
Material And Method: The present cross sectional study was conducted in healthy women, with intact uterus and at least one ovary, attending the university hospital menopausal clinic. They had no history of pelvic mass, paralysis or using any diuretic.
Objectives: To determine response, complication and survival of uterine cervical cancer patients treated with concurrent gemcitabine radiotherapy.
Material And Method: A retrospective review of medical records of 41 patients with uterine cervical cancer patients, stage IIB and above treated with concurrent gemcitabine radiotherapy from August 2000 to August 2003.
Results: At 6 and 12 months of follow up, the complete response rate was 75.